Back to search

Article

Piloting New Medications for Borderline Personality Disorder: The Use of Artificial Intelligence in Psycho-Pharmacological Research

2026-05-05

Abstract excerpt

<h4>Background: </h4> Borderline Personality Disorder (BPD) lacks approved pharmacological treatments despite a high symptom burden. Artificial intelligence (AI) offers new opportunities to accelerate drug discovery and model therapeutic effects. <h4>Objective:</h4> This study will outline an AI‑enabled framework for identifying and modelling a novel pharmacological agent for BPD, designed to meet five therapeutic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8ed6a08d-8569-526f-b6af-126ae08622b4
DOI
10.20944/preprints202605.0154.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Piloting New Medications for Borderline Personality Disorder: The Use of Artificial Intelligence in Psycho-Pharmacological ResearchDOI 10.20944/preprints202605.0154.v1
Exploring Advanced Applications of Artificial Intelligence in Neuropharmacology: A Comprehensive OverviewSemantic proximity
Artificial Intelligence Meets Drug Discovery: A Systematic Review on AI-Powered Target Identification and Molecular DesignSemantic proximity
Artificial Intelligence – Guided Cancer Therapy for Patients with Migraine ComorbiditiesSemantic proximity
Role of Artificial Intelligence in Modern Drug Discovery: A Literature OverviewSemantic proximity
Machine learning detects predictors of symptom severity and impulsivity after dialectical behavior therapy skills training group in borderline personality disorderSemantic proximity
Development and Validation of a Deep-Learning Model for Differential Treatment Benefit Prediction for Adults with Major Depressive Disorder Deployed in the Artificial Intelligence in Depression – Medication Enhancement (AID-ME) StudySemantic proximity
Artificial Intelligence in Mental Health Treatment and ResearchSemantic proximity
An Artificial Intelligence Framework for Optimal Drug DesignSemantic proximity
Drug REpurposing using AI/ML tools - for Rare Diseases (DREAM-RD): A case study with Fragile X Syndrome (FXS)Semantic proximity
Artificial Intelligence for Post-Marketing Pharmacovigilance of Herbal and Botanical Medicines: A Scoping Review and the MIAHPV FrameworkSemantic proximity
Leveraging Generative AI to Prioritize Drug Repurposing Candidates: Validating Identified Candidates for Alzheimer’s Disease in Real-World Clinical DatasetsSemantic proximity
Depression diagnosis using Artificial Intelligence: a systematic reviewSemantic proximity
Select a neighboring publication to make it the new centre.